Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Amphetamine withdrawal: depression and M.H.P.G. excretion.

× No keyword cloud information.

7 in total

1. New horizons in psychopharmacology.

Authors: W Linford
Journal: Proc R Soc Med Date: 1972-09

2. Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice.

Authors: Nobue Kitanaka; Junichi Kitanaka; Tomohiro Tatsuta; Koh-ichi Tanaka; Kaname Watabe; Nobuyoshi Nishiyama; Yoshio Morita; Motohiko Takemura
Journal: Neurochem Res Date: 2010-02-11 Impact factor: 3.996

3. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.

Authors: P E Paulson; D M Camp; T E Robinson
Journal: Psychopharmacology (Berl) Date: 1991 Impact factor: 4.530

4. A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.

Authors: G P Galloway; R Buscemi; J R Coyle; K Flower; J D Siegrist; L A Fiske; M J Baggott; L Li; D Polcin; C Y A Chen; J Mendelson
Journal: Clin Pharmacol Ther Date: 2010-12-22 Impact factor: 6.875

Amphetamine withdrawal: depression and M.H.P.G. excretion.

1. New horizons in psychopharmacology.

2. Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice.

3. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.

4. A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.

5. Amphetamine withdrawal: effects on threshold of intracranial reinforcement.

Review 6. Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.

Review 7. Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review.